|
BRPI0714886B8
(pt)
|
2006-07-10 |
2021-05-25 |
Paion Uk Ltd |
sais de benzodiazepina, seus usos e seus processos de preparação, e composição farmacêutica
|
|
EP3050885B1
(en)
*
|
2009-11-05 |
2017-10-18 |
GlaxoSmithKline LLC |
Benzodiazepine bromodomain inhibitor
|
|
EP2571875A4
(en)
|
2010-05-14 |
2013-10-30 |
Dana Farber Cancer Inst Inc |
CONTRACEPTIVE COMPOSITIONS FOR MEN AND METHODS OF USE THEREOF
|
|
MX354217B
(es)
|
2010-05-14 |
2018-02-19 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para el tratamiento de leucemia.
|
|
JP5715241B2
(ja)
*
|
2010-05-14 |
2015-05-07 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
|
|
PL2902030T3
(pl)
|
2010-05-14 |
2017-07-31 |
Dana-Farber Cancer Institute, Inc. |
Związki tienotriazolodiazepinowe do leczenia nowotworu
|
|
EP2450039A1
(en)
|
2010-11-08 |
2012-05-09 |
PAION UK Ltd. |
Dosing regimen for sedation with CNS 7056 (Remimazolam)
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
WO2012075456A1
(en)
|
2010-12-02 |
2012-06-07 |
Constellation Pharmaceuticals |
Bromodomain inhibitors and uses thereof
|
|
US9422292B2
(en)
|
2011-05-04 |
2016-08-23 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
WO2012174487A2
(en)
|
2011-06-17 |
2012-12-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201114103D0
(en)
*
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013033268A2
(en)
*
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
CA2870931A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Isoindolone derivatives
|
|
PE20150683A1
(es)
*
|
2012-05-22 |
2015-06-03 |
Paion Uk Ltd |
Composiciones que comprenden benzodiazepinas de accion corta
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
AU2012382373A1
(en)
|
2012-06-12 |
2014-12-11 |
Abbvie Inc. |
Pyridinone and pyridazinone derivatives
|
|
EP2885286B1
(de)
|
2012-08-16 |
2017-03-22 |
Bayer Pharma Aktiengesellschaft |
2,3-benzodiazepine
|
|
JP2015524847A
(ja)
*
|
2012-08-16 |
2015-08-27 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ |
小細胞肺がんを治療するためのベンゾジアゼピン
|
|
EP2900672B1
(de)
*
|
2012-09-28 |
2017-02-22 |
Bayer Pharma Aktiengesellschaft |
Bet-proteininhibitorische 5-aryl-triazolo-azepine
|
|
JP2016507496A
(ja)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． |
ブロモドメイン阻害剤としての新規複素環式化合物
|
|
AR094963A1
(es)
|
2013-03-04 |
2015-09-09 |
Ono Pharmaceutical Co |
Reacción de oxidación excelente en el índice de conversión
|
|
MX2015012158A
(es)
*
|
2013-03-11 |
2015-12-01 |
Abbvie Inc |
Inhibidores de bomodominio tetraciclicos fusionados.
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
UY35395A
(es)
*
|
2013-03-12 |
2014-10-31 |
Abbvie Inc |
Inhibidores de bromodominios tetracíclicos
|
|
EA201591746A1
(ru)
|
2013-03-14 |
2016-08-31 |
КОНВЕРДЖЕН ЭлЭлСи |
Способы и композиции для ингибирования бромодомен-содержащих белков
|
|
WO2014159392A1
(en)
|
2013-03-14 |
2014-10-02 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
SG11201506924YA
(en)
|
2013-03-15 |
2015-09-29 |
Incyte Corp |
Tricyclic heterocycles as bet protein inhibitors
|
|
US9393232B2
(en)
|
2013-04-26 |
2016-07-19 |
Beigene, Ltd. |
Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
|
|
CN104146970A
(zh)
*
|
2013-05-05 |
2014-11-19 |
王元青 |
治疗精神疾病的冻干粉针剂
|
|
CN103202815B
(zh)
*
|
2013-05-05 |
2014-09-24 |
李友香 |
治疗精神疾病的注射剂
|
|
SI3010503T1
(sl)
|
2013-06-21 |
2020-07-31 |
Zenith Epigenetics Ltd. |
Novi biciklični inhibitorji bromodomene
|
|
JP6461118B2
(ja)
|
2013-06-21 |
2019-01-30 |
ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． |
ブロモドメイン阻害剤としての新規の置換された二環式化合物
|
|
EP3019502B1
(en)
|
2013-07-08 |
2017-05-17 |
Incyte Holdings Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
US9975896B2
(en)
|
2013-07-25 |
2018-05-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
JP6542212B2
(ja)
|
2013-07-31 |
2019-07-10 |
ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． |
ブロモドメイン阻害剤としての新規キナゾリノン
|
|
RU2016122654A
(ru)
|
2013-11-08 |
2017-12-14 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка
|
|
US9399640B2
(en)
|
2013-11-26 |
2016-07-26 |
Incyte Corporation |
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
|
|
WO2015081189A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
GB201320994D0
(en)
*
|
2013-11-28 |
2014-01-15 |
Univ Dundee |
Enzyme function probes
|
|
WO2015095492A1
(en)
|
2013-12-19 |
2015-06-25 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
CN105940005A
(zh)
|
2014-01-31 |
2016-09-14 |
达纳-法伯癌症研究所股份有限公司 |
二氮杂环庚烷衍生物及其用途
|
|
EP3099677A4
(en)
|
2014-01-31 |
2017-07-26 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
|
EP3105232B1
(en)
|
2014-02-10 |
2019-08-28 |
Concert Pharmaceuticals Inc. |
Substituted triazolobenzodiazepines
|
|
WO2015131005A1
(en)
|
2014-02-28 |
2015-09-03 |
The Regents Of The University Of Michigan |
9h-pyrimido[4,5-b]indoles and related analogs as bet bromodomain inhibitors
|
|
JP2017506666A
(ja)
|
2014-02-28 |
2017-03-09 |
テンシャ セラピューティクス，インコーポレイテッド |
高インスリン血症に関連した症状の処置
|
|
WO2015156601A1
(en)
|
2014-04-09 |
2015-10-15 |
Kainos Medicine, Inc. |
Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer
|
|
PL3134403T3
(pl)
|
2014-04-23 |
2020-07-13 |
Incyte Corporation |
1H-pirolo[2,3-c]pirydyn-7(6H)-ony i pirazolo[3,4-c]pirydyn-7(6H)-ony jako inhibitory białek BET
|
|
US20170121322A1
(en)
*
|
2014-06-18 |
2017-05-04 |
Bayer Pharma Aktiengesellschaft |
Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groups
|
|
PL3157928T3
(pl)
|
2014-06-20 |
2019-07-31 |
Constellation Pharmaceuticals, Inc. |
Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu
|
|
CN106793775B
(zh)
|
2014-08-08 |
2020-06-02 |
达纳-法伯癌症研究所股份有限公司 |
二氢碟啶酮衍生物及其用途
|
|
CN106715437A
(zh)
|
2014-08-08 |
2017-05-24 |
达纳-法伯癌症研究所股份有限公司 |
二氮杂环庚烷衍生物及其用途
|
|
JP6599979B2
(ja)
|
2014-09-15 |
2019-10-30 |
インサイト・コーポレイション |
Ｂｅｔタンパク質阻害剤として用いるための三環式複素環化合物
|
|
CA2960090A1
(en)
*
|
2014-10-02 |
2016-04-07 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Compound
|
|
KR20170068597A
(ko)
|
2014-10-27 |
2017-06-19 |
텐샤 세러퓨틱스 인코포레이티드 |
브로모도메인 저해제
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
US10179125B2
(en)
|
2014-12-01 |
2019-01-15 |
Zenith Epigenetics Ltd. |
Substituted pyridines as bromodomain inhibitors
|
|
US10710992B2
(en)
|
2014-12-01 |
2020-07-14 |
Zenith Epigenetics Ltd. |
Substituted pyridinones as bromodomain inhibitors
|
|
WO2016092375A1
(en)
|
2014-12-11 |
2016-06-16 |
Zenith Epigenetics Corp. |
Substituted heterocycles as bromodomain inhibitors
|
|
CA2966450A1
(en)
|
2014-12-17 |
2016-06-23 |
Olesya KHARENKO |
Inhibitors of bromodomains
|
|
EP3262045A1
(en)
|
2015-02-27 |
2018-01-03 |
The Regents of The University of Michigan |
9h-pyrimido [4,5-b]indoles as bet bromodomain inhibitors
|
|
GB201504694D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Covalent conjugates
|
|
CA2981503C
(en)
|
2015-03-31 |
2023-09-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
WO2016171470A1
(en)
*
|
2015-04-21 |
2016-10-27 |
Kainos Medicine, Inc. |
Bromodomain-inhibiting compounds and methods to prevent or treat a cancer
|
|
WO2016196065A1
(en)
|
2015-05-29 |
2016-12-08 |
Genentech, Inc. |
Methods and compositions for assessing responsiveness of cancers to bet inhibitors
|
|
WO2016201370A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
US20180193350A1
(en)
|
2015-06-26 |
2018-07-12 |
Tensha Therapeutics, Inc. |
Treatment of nut midline carcinoma
|
|
JP6765622B2
(ja)
*
|
2015-07-17 |
2020-10-07 |
日本光電工業株式会社 |
救命支援装置
|
|
DK3324977T3
(da)
|
2015-07-22 |
2022-10-17 |
Enanta Pharm Inc |
Benzodiazepinderivater som rsv-inhibitorer
|
|
EP3347021A4
(en)
|
2015-09-11 |
2019-07-24 |
Dana-Farber Cancer Institute, Inc. |
CYANOTHIENOTRIAZOLDIAZEPINE AND USES THEREOF
|
|
RU2018112953A
(ru)
|
2015-09-11 |
2019-10-14 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Ацетамидтиенотриазолодиазепины и пути их применения
|
|
WO2017075377A1
(en)
|
2015-10-29 |
2017-05-04 |
Incyte Corporation |
Amorphous solid form of a bet protein inhibitor
|
|
MX2018006499A
(es)
|
2015-11-25 |
2018-08-01 |
Dana Farber Cancer Inst Inc |
Inhibidores de bromodominio bivalentes y usos de los mismos.
|
|
CN106892924B
(zh)
*
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
|
EP3402799B1
(en)
|
2016-01-15 |
2022-05-04 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as rsv inhibitors
|
|
US11548899B2
(en)
|
2016-02-15 |
2023-01-10 |
The Regents Of The University Of Michigan |
Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors
|
|
US10759808B2
(en)
|
2016-04-06 |
2020-09-01 |
The Regents Of The University Of Michigan |
Monofunctional intermediates for ligand-dependent target protein degradation
|
|
SG11201808728QA
(en)
|
2016-04-06 |
2018-11-29 |
Univ Michigan Regents |
Mdm2 protein degraders
|
|
KR20180132861A
(ko)
|
2016-04-12 |
2018-12-12 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
Bet 단백질 분해제
|
|
PT3442972T
(pt)
|
2016-04-15 |
2020-05-29 |
Abbvie Inc |
Inibidores de bromodomínio
|
|
WO2017189651A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2017189663A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
US10080741B2
(en)
|
2016-04-26 |
2018-09-25 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as FXR agonists and methods of use thereof
|
|
DE102017005089A1
(de)
|
2016-05-30 |
2017-11-30 |
Bayer Pharma Aktiengesellschaft |
Substitulerte 3,4-Dihydrochinoxalin-2(1H)-one
|
|
DE102017005091A1
(de)
|
2016-05-30 |
2017-11-30 |
Bayer Pharma Aktiengesellschaft |
Substituierte 3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one
|
|
CA3028689A1
(en)
|
2016-06-20 |
2017-12-28 |
Incyte Corporation |
Crystalline solid forms of a bet inhibitor
|
|
CN107629057B
(zh)
*
|
2016-07-19 |
2020-03-27 |
上海勋和医药科技有限公司 |
Bet蛋白抑制剂及其应用
|
|
US10918647B2
(en)
|
2016-07-26 |
2021-02-16 |
University Of Southern California |
Selective bromodomain inhibition of fungal Bdf1
|
|
CA3036834A1
(en)
|
2016-09-13 |
2018-03-22 |
The Regents Of The University Of Michigan |
Fused 1,4-oxazepines as bet protein degraders
|
|
CA3036841A1
(en)
|
2016-09-13 |
2018-03-22 |
The Regents Of The University Of Michigan |
Fused 1,4-diazepines as bet protein degraders
|
|
MX2019003790A
(es)
|
2016-10-04 |
2019-09-26 |
Enanta Pharm Inc |
Analogos de isoxazol como agonistas de fxr y metodos de uso de los mismos.
|
|
WO2018081285A1
(en)
|
2016-10-26 |
2018-05-03 |
Enanta Pharmaceuticals, Inc. |
Urea-containing isoxazole derivatives as fxr agonists and methods of use thereof
|
|
CA3045855A1
(en)
|
2016-11-10 |
2018-05-17 |
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. |
Nitrogenous macrocyclic compound, preparation method therefor, pharmaceutical composition and application thereof
|
|
US10398706B2
(en)
|
2017-01-06 |
2019-09-03 |
Enanta Pharmaceuticals, Inc. |
Heteroaryldiazepine derivatives as RSV inhibitors
|
|
WO2018144789A1
(en)
|
2017-02-03 |
2018-08-09 |
The Regents Of The University Of Michigan |
Fused 1,4-diazepines as bet bromodomain inhibitors
|
|
CN110809472B
(zh)
|
2017-02-16 |
2023-05-23 |
英安塔制药有限公司 |
用于制备苯二氮䓬衍生物的方法
|
|
CN108727380A
(zh)
*
|
2017-04-13 |
2018-11-02 |
中国科学院上海药物研究所 |
一种brd4抑制剂及其制备和应用
|
|
CN110418791B
(zh)
*
|
2017-04-28 |
2022-07-01 |
四川科伦博泰生物医药股份有限公司 |
包含苯并二氮䓬类化合物的注射用组合物及其制备方法
|
|
CN108948018B
(zh)
*
|
2017-05-17 |
2021-03-30 |
四川科伦博泰生物医药股份有限公司 |
苯并二氮*衍生物及其盐和相关晶体形式、制备方法和用途
|
|
WO2018226801A1
(en)
|
2017-06-07 |
2018-12-13 |
Enanta Pharmaceuticals, Inc. |
Aryldiazepine derivatives as rsv inhibitors
|
|
US11091501B2
(en)
|
2017-06-30 |
2021-08-17 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as RSV inhibitors
|
|
WO2019006291A1
(en)
|
2017-06-30 |
2019-01-03 |
Enanta Pharmaceuticals, Inc. |
HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
|
|
WO2019055444A1
(en)
|
2017-09-13 |
2019-03-21 |
The Regents Of The University Of Michigan |
DEGRADATION AGENTS OF BROMODOMAIN BET PROTEIN WITH CLEAR BINDERS
|
|
EP3686204B1
(en)
*
|
2017-09-22 |
2025-11-05 |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
Thienodiazepine derivatives and application thereof
|
|
BR112020006334A2
(pt)
|
2017-09-29 |
2020-09-24 |
Enanta Pharmaceuticals, Inc. |
combinação de agentes farmacêuticos como inibidores de rsv
|
|
CA3080138A1
(en)
|
2017-11-13 |
2019-05-16 |
Enanta Pharmaceuticals, Inc. |
Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
|
|
US10647711B2
(en)
|
2017-11-13 |
2020-05-12 |
Enanta Pharmaceuticals, Inc. |
Azepin-2-one derivatives as RSV inhibitors
|
|
US10689391B2
(en)
|
2017-12-12 |
2020-06-23 |
Enanta Pharmaceuticals, Inc. |
Isoxazole analogs as FXR agonists and methods of use thereof
|
|
WO2019160813A1
(en)
|
2018-02-14 |
2019-08-22 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2019199908A1
(en)
|
2018-04-11 |
2019-10-17 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as rsv inhibitors
|
|
WO2020055976A1
(en)
*
|
2018-09-11 |
2020-03-19 |
Genentech, Inc. |
Tert-butyl (s)-2-(4-(phenyl)-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain brd4 inhibitors for treating cancer
|
|
JP7292400B2
(ja)
*
|
2019-03-07 |
2023-06-16 |
メッドシャイン ディスカバリー インコーポレイテッド |
ＢＥＴ Ｂｒｏｍｏｄｏｍａｉｎタンパク質の阻害とＰＤ－Ｌ１遺伝子の調節の両方の効果を持つ化合物
|
|
BR112021018335A2
(pt)
|
2019-03-18 |
2021-11-23 |
Enanta Pharm Inc |
Derivados de benzodiazepina como inibidores de rsv
|
|
WO2020210246A1
(en)
|
2019-04-09 |
2020-10-15 |
Enanta Pharmaceuticals, Inc, |
Heterocyclic compounds as rsv inhibitors
|
|
GB201905721D0
(en)
|
2019-04-24 |
2019-06-05 |
Univ Dundee |
Compounds
|
|
WO2020231917A1
(en)
|
2019-05-13 |
2020-11-19 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
AU2020357452B2
(en)
|
2019-10-04 |
2026-01-29 |
Enanta Pharmaceuticals, Inc |
Antiviral heterocyclic compounds
|
|
US11505558B1
(en)
|
2019-10-04 |
2022-11-22 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
PT116050B
(pt)
*
|
2020-01-09 |
2022-06-15 |
Hovione Farm S A |
Conjugados fármaco-ligando e inibidores das proteínas da família bromodomínio e domínio extraterminal -(bet) modificados
|
|
UY39032A
(es)
|
2020-01-24 |
2021-07-30 |
Enanta Pharm Inc |
Compuestos heterocíclicos como agentes antivirales
|
|
WO2021175432A1
(en)
|
2020-03-04 |
2021-09-10 |
Boehringer Ingelheim International Gmbh |
Method for administration of an anti cancer agent
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
IL299163A
(en)
|
2020-06-23 |
2023-02-01 |
Genentech Inc |
Macrocyclic compounds and methods of using them
|
|
WO2022010882A1
(en)
|
2020-07-07 |
2022-01-13 |
Enanta Pharmaceuticals, Inc, |
Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
|
|
US11945824B2
(en)
|
2020-10-19 |
2024-04-02 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as anti-viral agents
|
|
GB202016977D0
(en)
|
2020-10-26 |
2020-12-09 |
In4Derm Ltd |
Compounds
|
|
CN114456171A
(zh)
*
|
2020-11-09 |
2022-05-10 |
中国药科大学 |
一类用于镇静催眠的苯并二氮䓬类药物、其制备方法及应用
|
|
CN112358483A
(zh)
*
|
2020-11-09 |
2021-02-12 |
中国药科大学 |
一类新型苯并二氮*类化合物、其制备方法及其用途
|
|
WO2022182861A1
(en)
|
2021-02-26 |
2022-09-01 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
US12612412B2
(en)
|
2021-02-26 |
2026-04-28 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
CA3224302A1
(en)
|
2021-06-29 |
2023-01-05 |
Tay Therapeutics Limited |
Pyrrolopyridone derivatives useful in the treatment of cancer
|
|
AR129003A1
(es)
|
2022-04-07 |
2024-07-03 |
Enanta Pharm Inc |
Compuestos heterocíclicos antivirales
|
|
WO2023205251A1
(en)
|
2022-04-19 |
2023-10-26 |
Nuevolution A/S |
Compounds active towards bromodomains
|
|
WO2023211997A1
(en)
|
2022-04-27 |
2023-11-02 |
Enanta Pharmaceuticals, Inc. |
Antiviral compounds
|
|
US20260000642A1
(en)
|
2022-07-21 |
2026-01-01 |
Tay Therapeutics Limited |
Pyrroles and imidazoles as bet protein inhibitors
|